BY ANALOU DE VERA
The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the COVID-19 vaccine developed by British drug-maker AstraZeneca.
“After a thorough review of the currently available data by our medical and regulatory experts, the FDA is granting an emergency use authorization to the COVID-19 vaccine AstraZeneca,” said FDA Director-General Rolando Enrique Domingo in a public press briefing.